We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00472342
Recruitment Status : Unknown
Verified May 2007 by Yonsei University.
Recruitment status was:  Recruiting
First Posted : May 11, 2007
Last Update Posted : May 11, 2007
Information provided by:
Yonsei University

Brief Summary:

Many adipokines are thought that related with metabolic disturbance such as glucose intolerance, dyslipidemia, and insulin resistance. It is reported that regular physical training could prevent the progression of diabetes from prediabetes and improve the insulin resistance. After physical training, many adipokine levels were changed due to improving insulin resistance.

In this study, we will examine the various adipokine levels such as adiponectin, RBP-4, and adrenomedullin after exercise training through exercise prescription in IFG and IGT patients.

Condition or disease Intervention/treatment
Impaired Glucose Tolerance Diabetes Behavioral: exercise prescription

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 182 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: The Effects of Exercise on Adipokine in Impaired Fasting Glucose or Impaired Glucose Tolerance Patients
Study Start Date : March 2007
Estimated Study Completion Date : December 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. Improvements of adipokine levels [ Time Frame: 6 Months ]

Secondary Outcome Measures :
  1. Prevention of diabetes [ Time Frame: 1~5 year ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   30 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Age; 30~70
  2. Subjects with IGT and IFG
  3. Subjects with having possibility of exercise stress test
  4. Subjects with having a strong will to this study

Exclusion Criteria:

  1. Age <30 or >70
  2. Cr more than 1.5 mg/dL
  3. AST, ALT levels more than twice as upper normal range
  4. Subjects having past history of coronary artery disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00472342

Contact: Choon Hee Chung, Prefessor 82-33-741-0506 cchung@yonsei.ac.kr

Korea, Republic of
Mi Young Lee Recruiting
Wonju, Kangwon-Do, Korea, Republic of, 220-701
Contact: Mi Young Lee, Dr    82-33-741-0681    domoe46@yonsei.ac.kr   
Sponsors and Collaborators
Yonsei University
Principal Investigator: Mi Young Lee, Dr Department of Internal Medicine, Yonsei University Wonju College of Medicine
Study Chair: Choon Hee Chung, professor Department of Internal Medicine, Yonsei Univerisity Wonju College of Medicine

ClinicalTrials.gov Identifier: NCT00472342     History of Changes
Other Study ID Numbers: kenshin46
First Posted: May 11, 2007    Key Record Dates
Last Update Posted: May 11, 2007
Last Verified: May 2007

Keywords provided by Yonsei University:
impaired glucose tolerance
impaired fasting glucose

Additional relevant MeSH terms:
Glucose Intolerance
Glucose Metabolism Disorders
Metabolic Diseases